Infrastructure-as-code management platform Spacelift nabs $15M
16 Oct, 2021
Iterion Therapeutics Lands $17M Series B
– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing.
РThe round was led by Lumira Ventures, with the participation of existing investors, including Sant̩ Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.
